NCT06576999Completed
Sensor-based Balance Training With Exergaming Biofeedback
Sensor-based Balance Training With Exergaming Feedback in Patients With Chronic Stroke
Source: ClinicalTrials.gov · Last updated 29 Aug 2024
Brief summary (registry, in English)
The purpose of this study is to evaluate the effects of a sensor-based balance training with exergaming feedback on balance skills in chronic stroke patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 21 (actual)
- First submitted
- 20 Aug 2024
- Start date
- 1 May 2017
- Primary completion date
- 27 Jul 2024
- Lead sponsor
- I.R.C.C.S. Fondazione Santa Lucia
- Diseases
- Stroke
- NCT number
- NCT06576999
What you commit to
- Study type: Interventional
- Participants enrolled: 21
- From 1 May 2017 to the primary completion date, 27 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Severe general impairment or concomitant diseases (i.e., Parkinson disease).
Other illness
- Cognitive impairment (MINI MENTAL STATE EXAMINATION \< 23).
Other
- Orthopaedic contraindications.
- Diagnosis of unilateral spatial neglect.
Who the study is looking for
- Single event of cortical/subcortical ischemic stroke.
- Onset \> 180 days.
- Lesion confirmed thought magnetic resonance (MR) or computer tomography (CT).
- Able to stand upright with supervision or minimal assistance.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Santa Lucia Foundation Coordinator of this site? Confirm its status | Rome | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.